Aims We aimed to investigate the association of clinically overt and silent brain lesions with
cognitive function in atrial fibrillation (AF) patients. Methods and results We enrolled 1227 AF …

Background The incidence and predictors of atrial fibrillation (AF) progression are currently
not well defined, and clinical AF progression partly overlaps with rhythm control …

Background Hospitalization for heart failure (HF) is very common in patients with atrial
fibrillation (AF). We hypothesized that biomarkers of inflammation can identify patients with …

Background Evidence for the association of atrial fibrillation (AF) present on the ECG and
cardiovascular outcomes in AF patients is limited. Objective To investigate the prognostic …

Background Optimizing health‐related quality of life (HRQoL) is an important aim of atrial
fibrillation (AF) treatment. Little is known about patients' long‐term HRQoL trajectories and …

Background Previous randomized control trials showed mixed results concerning the effect
of omega‐3 fatty acids (n‐3 FAs) on atrial fibrillation (AF). The associations of n‐3 FA blood …

Objective Balancing bleeding risk and stroke risk in patients with atrial fibrillation (AF) is a
common challenge. Though several bleeding risk scores exist, most have not included …

Aims Atrial fibrillation (AF) and frailty are common, and the prevalence is expected to rise
further. We aimed to investigate the prevalence of frailty and the ability of a frailty index (FI) …

Background Patients with atrial fibrillation (AF) face an increased risk of death and major
adverse cardiovascular events (MACE). We aimed to assess the predictive value of the …

Objective Serum neurofilament light chain (sNfL) is increasingly used as a neuroaxonal
injury biomarker in the elderly. Besides age, little is known about how other physiological …